Small Molecules
19 April 2016
Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)19 April 2016
Dynavax Presents Encouraging Data From Clinical Trial of Immuno-Oncology Product Candidate, SD-10118 April 2016
TECFIDERA® Data Confirm Strong and Sustained Efficacy in Newly Diagnosed MS Patients and Real-World Effectiveness18 April 2016
Medivation Announces Presentation of Phase I Talazoparib Combination Data in Several Advanced Cancers18 April 2016
BerGenBio Presents New Data Demonstrating That BGB324 Enhances Checkpoint Inhibitor Blockade17 April 2016
FDA approves Gilotrif® (afatinib) as new oral treatment option for patients with squamous cell carcinoma of the lung14 April 2016
Zavante Initiates The ZEUS Study For ZTI-01 For The Treatment Of Complicated Urinary Tract Infections14 April 2016
Celprogen’s Novel CEP1430 & CEP1507 Compounds for Targeting Advanced Stage Pancreatic Cancer Patients13 April 2016
Karos Pharmaceuticals Advances Development of KAR5585 to Treat Pulmonary Arterial Hypertension into the ClinicNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports